1. P432 Barriers to prescribing anti-TNF therapy in inflammatory bowel disease (IBD) across newly industrialised emerging market countries: an analysis of the 'EXPLORE' study. (25th January 2019) Authors: Ye, B D; Yamamoto Furusho, J K; Rana Qasim Khan, M; Fadeeva, O; Demuth, D; Qian, J; Khalif, I L; Chia-Hung, T; Toruner, M; Othman, A H; Chan, W; Ponce de Leon, E; Guennec, M; Sison, C; Uberti Foppa, E; Armuzzi, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. (17th March 2021) Authors: Kucharzik, T; Ellul, P; Greuter, T; Rahier, J F; Verstockt, B; Abreu, C; Albuquerque, A; Allocca, M; Esteve, M; Farraye, F A; Gordon, H; Karmiris, K; Kopylov, U; Kirchgesner, J; MacMahon, E; Magro, F; Maaser, C; de Ridder, L; Taxonera, C; Toruner, M Journal: Journal of Crohn's and colitis Issue: Volume 15:Number 6(2021) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P401 Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis. (30th January 2023) Authors: Toruner, M; Guvenir, T; Er, R E; Soykan, I Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗